Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Letter to the Editor

Generation of an Adult Smooth Muscle Cell–Targeted Cre Recombinase Mouse Model

Jifeng Zhang, Wei Zhong, Taixing Cui, Maozhou Yang, Xing Hu, Kefeng Xu, Changqing Xie, Changyong Xue, Gary H. Gibbons, Chengyu Liu, Li Li, Yuqing E. Chen
Download PDF
https://doi.org/10.1161/01.ATV.0000202661.61837.93
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:e23-e24
Originally published March 31, 2006
Jifeng Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Zhong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taixing Cui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maozhou Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing Hu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kefeng Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changqing Xie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changyong Xue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary H. Gibbons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengyu Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuqing E. Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

This article has a correction. Please see:

  • Correction - April 01, 2006
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

To the Editor:

The smooth muscle cell (SMC)–targeted Cre recombination mice are critical tools for in vivo analysis of gene function in the vasculature and for establishing animal models for cardiovascular diseases. Therefore, there is a continuing effort to generate SMC-targeted Cre recombinase mice for in vivo loss-of-gene function studies. Currently, several genetically engineered mice express the Cre-recombinase under the control of SMC-specific promoters such as SM22α (also known as transgelin, a 22-kDa protein that is abundantly and exclusively expressed in SMCs of adult animals) promoters and smooth muscle myosin heavy chain promoters.1–6 However, there are potential limitations in their uses for knockout studies; some of them show relatively low excision efficiency and potential embryonic lethality, which prevent subsequent in vivo analyses in adult SMCs. In our effort to generate an SMC-targeted Cre recombination mouse line that effectively excises loxP-flanked target gene, we obtained a valuable Cre recombinase mouse (SM22α-CreKI) that unexpectedly does not express Cre recombinase in embryonic SMCs and cardiac myocytes but highly expresses the Cre in adult SMCs and cardiac myocytes.

This SM22α-CreKI mouse line was generated by knocking in the Cre-recombinase coding sequence into the endogenous SM22α gene locus via homologous recombination of embryonic stem cells (supplemental Figure S1, available online at http://atvb.ahajournals.org). Consistent with previous reports of SM22α knockout mice, our SM22α-CreKI heterozygous and homozygous mice were fertile and appeared phenotypically normal.

To determine the temporospatial patterns of Cre-mediated recombination in SM22α-CreKI mice, we crossed the homozygous SM22α-CreKI mice with the reporter mice Gt(Rosa)26Sor (The Jackson Laboratory, Bar Harbor, Me; cat. 003309). As shown in the Figure, A, we found that the Cre expression in a heterozygous mouse is sufficient to induce homologous recombination at loxP sites and thus to remove the loxP-flanked STOP signal between the lacZ gene and the Gt(Rosa)26Sor promoter, which leads to β-galactosidase (β-gal) activities. We observed β-gal–positive staining in almost all adult SMCs that comprise the medial layer of all large and small arteries and veins, including the arterial circle of Willis, aorta, femoral arteries and veins, the pulmonary artery, small arteries in skeletal muscles, and coronary arteries (Figure, A). The Cre-mediated recombination in vascular SMCs occurs in all of the arteries and veins we examined (Figure, A; online supplement S2). Consistent with the expression pattern of endogenous SM22α, β-gal–positive staining in the visceral SMCs, including the bladder and gastrointestinal tract in adult mice is observed at high efficiency (Figure, A; online supplement S2). In addition, β-gal activity is also found in cardiomyocytes (Figure, A). However, we found no β-gal–positive staining in other tissues such as brain, liver, and skeletal muscle cells.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Characterization of SM22α-CreKI mice. A, Cellular expression of Cre-recombinase in SM22α-CreKI mice. X-Gal–stained organs and sections were prepared from 8-week-old SM22α-CreKI and Gt(Rosa)26Sor double heterozygous mice or wild-type littermates. X-Gal staining shows that Cre-recombinase is expressed in SMCs and cardiomyocytes in adult. B, Western blot analyses show GFP protein expressed in the aorta and the heart of 8-week-old SM22α-CreKI and Gtrosa26 double heterozygous or double homozygous mice and the control wild-type littermates. GFP protein is the positive control. Wt indicates wild-type; A, aorta; B, brain; H, heart; M, skeletal muscle. Bar=100 μm.

Distinct from the endogenous SM22α expression, the SM22α-CreKI mice failed to exhibit specific β-gal activities in SMCs at all embryonic stages examined, ranging from embryonic day 9 to embryonic day 16.5 (online supplement S3). We detected β-gal activities in SMCs and the cardiac myocytes in newborn pups right after birth (day 1).

We also bred SM22α-CreKI mice with another reporter mouse model, Gt(Rosa)26Sor–green fluorescent protein (GFP; The Jackson Laboratory, Cat#: 004077) that contains an enhanced GFP (eGFP) gene inserted into the Gt(Rosa)26Sor locus. Consistent with the β-gal staining pattern, eGFP is expressed higher in the aorta, lower in the heart, but not in skeletal muscle and the brain by Western blot analyses (Figure 1B).

These results show that we generated an SM22α-CreKI mouse line that exhibits SMC-targeted Cre recombinase activities in all arteries, veins, visceral organs, and in cardiac myocytes in adults. This mouse line will be a useful addition to the diverse tools used to study the complicated smooth muscle and cardiac gene function in vivo in adult mice and to establish animal models for cardiovascular diseases.

References

  1. ↵
    Kuhbandner S, Brummer S, Metzger D, Chambon P, Hofmann F, Feil R. Temporally controlled somatic mutagenesis in smooth muscle. Genesis. . 2000; 28: 15–22.
    OpenUrlCrossRefPubMed
  2. ↵
    Regan CP, Manabe I, Owens GK. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Circ Res. . 2000; 87: 363–369.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A. . 2002; 99: 7142–7147.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Xin HB, Deng KY, Rishniw M, Ji G, Kotlikoff MI. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. Physiol Genomics. . 2002; 10: 211–215.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, Balza RO Jr, Xiao Q, Weiler H, Ginty DD, Misra RP. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A. . 2004; 101: 17132–17137.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Lepore JJ, Cheng L, Min Lu M, Mericko PA, Morrisey EE, Parmacek MS. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis. 2005; 41: 179–184.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
March 2006, Volume 26, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Generation of an Adult Smooth Muscle Cell–Targeted Cre Recombinase Mouse Model
    Jifeng Zhang, Wei Zhong, Taixing Cui, Maozhou Yang, Xing Hu, Kefeng Xu, Changqing Xie, Changyong Xue, Gary H. Gibbons, Chengyu Liu, Li Li and Yuqing E. Chen
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:e23-e24, originally published March 31, 2006
    https://doi.org/10.1161/01.ATV.0000202661.61837.93

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Generation of an Adult Smooth Muscle Cell–Targeted Cre Recombinase Mouse Model
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Generation of an Adult Smooth Muscle Cell–Targeted Cre Recombinase Mouse Model
    Jifeng Zhang, Wei Zhong, Taixing Cui, Maozhou Yang, Xing Hu, Kefeng Xu, Changqing Xie, Changyong Xue, Gary H. Gibbons, Chengyu Liu, Li Li and Yuqing E. Chen
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:e23-e24, originally published March 31, 2006
    https://doi.org/10.1161/01.ATV.0000202661.61837.93
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • Instructions for Authors
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured